Compare Novartis AG (NVS) vs iShares Broad USD Investment Grade Corporate Bond (USIG) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Novartis AG vs iShares Broad USD Investment Grade Corporate Bond — how do they compare? Novartis AG trades at $153.88 (market cap $290.25B), while iShares Broad USD Investment Grade Corporate Bond trades at $50.51. The key difference: Novartis AG pays a 3.17% dividend while iShares Broad USD Investment Grade Corporate Bond pays none, and Novartis AG is trading nearer its 52-week high, iShares Broad USD Investment Grade Corporate Bond nearer its low. Which is the better fit depends on your goals.
| NVS | USIG | |
|---|---|---|
Market Cap | $290.25B | — |
Sector | Health | Fixed Income |
52-Week High | $168.62 | $52.69 |
52-Week Low | $113.50 | $50.50 |
Enterprise Value | $330.27B | — |
Dividend Yield | 3.17% | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Novartis AG
Novartis develops and manufactures healthcare products through two segments: Innovative Medicines and Sandoz. It generates the vast majority of its revenue from Innovative Medicines segment consisting global business franchises in oncology, ophthalmology, neuroscience, immunology, respiratory, cardio-metabolic, and established medicines. The company sells its products globally, with the United States representing close to one third of total revenue.
Read more on NVS →About iShares Broad USD Investment Grade Corporate Bond
USIG is a low-cost ETF providing broad exposure to over 11,000 U.S. investment-grade corporate bonds. It tracks the ICE BofA US Corporate Index, featuring high-quality debt from 2026 leaders like Citigroup, Bank of America, and Oracle.
Read more on USIG →
